Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 7,192	$ 3,508	$ 11,259	$ 6,491
General and administrative	11,867	3,049	26,997	4,505
Total operating expenses	19,059	6,557	38,256	10,996
Loss from operations	(19,059)	(6,557)	(38,256)	(10,996)
Other income (expense):
Gain on change of fair value of Sponsor Earn-Out liability, net	28,958		21,270
Interest income	465	1	488	3
Other income (expense), net	(1,171)	(54)	(1,331)	788
Total other income (expense), net	28,252	(53)	20,427	791
Income (loss) before income taxes	9,193	(6,610)	(17,829)	(10,205)
Provision for income taxes	(178)	(19)	(189)	(19)
Net income (loss)	9,015	(6,629)	(18,018)	(10,224)
Other comprehensive income (loss):
Foreign currency translation adjustment	(1,377)	85	(1,268)	71
Total comprehensive income (loss)	$ 7,638	$ (6,544)	$ (19,286)	$ (10,153)
Net income (loss) per share attributable to common stockholders, basic (in dollars per share)	$ 0.03	$ (0.11)	$ (0.07)	$ (0.17)
Net income (loss) per share attributable to common stockholders, diluted (in dollars per share)	$ 0.03	$ (0.11)	$ (0.07)	$ (0.17)
Weighted-average shares outstanding, basic (in shares)	310,255,853	60,781,975	264,969,675	60,781,975
Weighted-average shares outstanding, diluted (in shares)	310,255,853	60,781,975	264,969,675	60,781,975